 Visit the TF Network Sites · Institutional Investor Center · Individual Investor Center |
| Download Plug-In |
| Real
Player 8 Basic Windows Media Player |
| Other Conference Calls |
| Other May 13 Calls Today's Calls |
| Call Details | |||
| Kensey Nash Corporation Announces Sale of Endovascular Business and Strategic Partnership With Spectranetics Conference Call Tue, May 13, 2008, 9:00 am Eastern
| |||
| About Spectranetics (NasdaqGM:SPNC) | Other Calls | ||
| The Spectranetics Corporation develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive surgical procedures within the cardiovascular system using its excimer laser technology. The company’s Excimer laser technology delivers relatively cool ultraviolet energy to remove arterial blockages, including plaque, calcium, and thrombus. It offers a range of proprietary laser devices designed for indications, including peripheral laser atherectomy in the upper and lower leg; and coronary laser atherectomy. The company’s peripheral laser atherectomy products include TURBO Elite Catheters for peripheral laser atherectomy; TURBO-Booster for the TURBO elite laser catheters facilitating directed laser ablation of blockages in the main arteries at or above the knee; and Quick-Cross Support Catheter that supports catheters for use in the cardiovascular system to support and assist standard guidewires to facilitate initial crossing of the blockage. Its coronary laser atherectomy products comprise disposable catheters consisting of Rapid Exchange Catheter, Over-The-Wire Catheter, POINT 9 Catheter, and Quick-Cross Support Catheter. The Spectranetics Corporation also offers devices for the removal of infected, defective, or abandoned pacemaker and implantable cardiac defibrillators leads. The company’s CVX-300 excimer laser unit includes Spectranetics Laser Sheath, a laser-assisted lead removal device; and Lead Locking Device, a mechanical device that assists in the removal of faulty leads by providing traction on the inner aspect of the leads, which are constructed of wire coils covered by insulating material. It operates in the United States, Canada, Mexico, South America, the Pacific Rim, and Australia. The Spectranetics Corporation was founded in 1984 and is based in Colorado Springs, Colorado. | |||
More Info: | |||
| About Kensey Nash Corporation (NasdaqGS:KNSY) | Other Calls | ||
| Kensey Nash Corporation, a medical device company, develops products and technologies in the fields of biomaterials and endovascular devices used in various medical procedures. It designs, develops, manufactures, and processes biomaterials products, such as absorbable polymer and collagen products for various applications, including orthopaedic, cardiology, drug/biologics delivery, periodontal, general surgery, and wound care. The company manufactures Angio-Seal components; orthopaedic products for various applications of biomaterials, which include soft tissue and bone fixation, bone void fillers, and scaffolds; and biomaterials-based products, including resorbable breast biopsy markers, dental barrier membranes, and wound care products designed for other market applications. It also designs, manufactures, markets, and sells thrombectomy and chronic total occlusion (CTO) devices. These products include ThromCat Thrombectomy Catheter System, QuickCat Extraction Catheter, and Safe-Cross radio frequency CTO system to remove thrombus (blood clots) from the patient during interventional procedures. The company sells its products through direct sales force primarily in the United States, as well as through distributors in other countries. Kensey Nash has partnership with Orthovita, Inc. to develop and commercialize Vitoss Foam and Vitoss Pack based on Orthovita’s proprietary Vitoss bone graft substitute material in combination with the company’s proprietary biomaterials. The company was founded in 1984 and is headquartered in Exton, Pennsylvania. | |||
More Info: | |||
